Gender Dysphoria Market to Expand Significantly by 2034, States DelveInsight Report | Schering-Plough

DelveInsight's "Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Gender Dysphoria, historical and forecasted epidemiology as well as the Gender Dysphoria market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Gender Dysphoria market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Gender Dysphoria Market Forecast
https://www.delveinsight.com/sample-request/gender-dysphoria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Gender Dysphoria Market Report:
• The Gender Dysphoria market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In March 2024, England's National Health Service (NHS) has ceased prescribing puberty blockers for children and adolescents with gender dysphoria, citing a lack of sufficient evidence on their safety and clinical effectiveness.
• In January 2024, The World Health Organization revealed that its Departments of Gender, Rights and Equity, Global HIV, Hepatitis and STIs, and Sexual and Reproductive Health and Research are creating guidelines aimed at improving the health of transgender and gender-diverse adults.
• In 2023, puberty suppression therapies were the largest revenue contributor in the US, amounting to approximately USD 20 million.
• In 2023, the UK generated the highest revenue among the EU4 and the UK, reaching approximately USD 20 million.
• In 2023, there were approximately 38,000 prevalent cases of Gender Dysphoria in the 7MM, and this number is expected to rise during the forecast period.
• In 2023, the prevalent population of Gender Dysphoria in the US was estimated to be around 13,000 cases.
• In the EU4 and the UK, the UK had the highest number of prevalent gender dysphoria cases, with approximately 8,500 cases, followed by Germany with around 5,000 cases.
• In 2023, the US accounted for the largest share of revenue in the 7MM, contributing approximately 45%.
• Key Gender Dysphoria Companies: Schering-Plough, and others
• Key Gender Dysphoria Therapies: testosterone undecanoate, and others
• The Gender Dysphoria epidemiology based on gender analyzed that this type of gender identity disorder occurs in one in 30,000 male births and one in 100,000 female births
• The Gender Dysphoria market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Gender Dysphoria pipeline products will significantly revolutionize the Gender Dysphoria market dynamics.

Get a Free sample for the Gender Dysphoria Market Report:
https://www.delveinsight.com/report-store/gender-dysphoria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Gender Dysphoria Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Gender Dysphoria Epidemiology Segmentation:
The Gender Dysphoria market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Prevalence of Gender Dysphoria in the 7MM
• Gender-specific Prevalence of Gender Dysphoria in the 7MM
• Comorbidities Associated with Gender Dysphoria in the 7MM

Download the report to understand which factors are driving Gender Dysphoria epidemiology trends @ Gender Dysphoria Epidemiology Forecast
https://www.delveinsight.com/sample-request/gender-dysphoria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Gender Dysphoria Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gender Dysphoria market or expected to get launched during the study period. The analysis covers Gender Dysphoria market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Gender Dysphoria Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Gender Dysphoria Therapies and Key Companies
• testosterone undecanoate: Schering-Plough

Discover more about therapies set to grab major Gender Dysphoria market share @ Gender Dysphoria Treatment Market
https://www.delveinsight.com/sample-request/gender-dysphoria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Gender Dysphoria Market Strengths
• Awareness amongst the masses has resulted in decreased stigma leading to increase in number of individuals opting for healthcare services
• Government initiatives to ensure proper treatment of GD patients has led to develop

Gender Dysphoria Market Opportunities
• Till date, there is no FDA approved therapy in market paving way for pharma players to come up with efficient and cost effective management options
• Increase in number of patients along with their positive attitude towards seeking care creates a market space with no competitors for therapy development

Scope of the Gender Dysphoria Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Gender Dysphoria Companies: Schering-Plough, and others
• Key Gender Dysphoria Therapies: testosterone undecanoate, and others
• Gender Dysphoria Therapeutic Assessment: Gender Dysphoria current marketed and Gender Dysphoria emerging therapies
• Gender Dysphoria Market Dynamics: Gender Dysphoria market drivers and Gender Dysphoria market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Gender Dysphoria Unmet Needs, KOL's views, Analyst's views, Gender Dysphoria Market Access and Reimbursement

To know more about Gender Dysphoria companies working in the treatment market, visit @ Gender Dysphoria Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/gender-dysphoria-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Gender Dysphoria Market Report Introduction
2. Executive Summary for Gender Dysphoria
3. SWOT analysis of Gender Dysphoria
4. Gender Dysphoria Patient Share (%) Overview at a Glance
5. Gender Dysphoria Market Overview at a Glance
6. Gender Dysphoria Disease Background and Overview
7. Gender Dysphoria Epidemiology and Patient Population
8. Country-Specific Patient Population of Gender Dysphoria
9. Gender Dysphoria Current Treatment and Medical Practices
10. Gender Dysphoria Unmet Needs
11. Gender Dysphoria Emerging Therapies
12. Gender Dysphoria Market Outlook
13. Country-Wise Gender Dysphoria Market Analysis (2020-2034)
14. Gender Dysphoria Market Access and Reimbursement of Therapies
15. Gender Dysphoria Market Drivers
16. Gender Dysphoria Market Barriers
17. Gender Dysphoria Appendix
18. Gender Dysphoria Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Gender Dysphoria Epidemiology https://www.delveinsight.com/report-store/gender-dysphoria-epidemiology-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Gender Dysphoria Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Gender Dysphoria epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight
• Antibody Drug Conjugate Market: https://www.delveinsight.com/report-store/antibody-drug-conjugate-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Tbi Market: https://www.delveinsight.com/report-store/traumatic-brain-injury-market
• Indwelling Catheters Market: https://www.delveinsight.com/report-store/indwelling-catheters-market
• Hyperlipidemia Market: https://www.delveinsight.com/report-store/hyperlipidemia-market
• Inflammatory Bowel Disease Market: https://www.delveinsight.com/report-store/crohns-disease-cd-market
• Post Menopausal Osteoporosis Market: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-pipeline-insight
• HiPost Menopausal Osteoporosis Market: https://www.delveinsight.com/report-store/post-menopausal-osteoporosis-pipeline-insight

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.